0.7473
Redhill Biopharma Ltd Adr (RDHL) 最新ニュース
RedHill Biopharma Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:RDHL) - TradingView
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement - Sahm
RedHill Biopharma closes $6 million private placement - Investing.com
RedHill Biopharma closes $6 million private placement By Investing.com - Investing.com South Africa
Form 6K Redhill Biopharma Ltd For: 22 June By Investing.com - Investing.com Nigeria
Form 6K RedHill Biopharma Ltd. For: 22 June By Investing.com - Investing.com South Africa
RedHill Biopharma raises $6M in private placement - Investing.com
RedHill Biopharma raises $6M in private placement By Investing.com - Investing.com South Africa
RedHill Biopharma Announces Up To $19.4 Million Private Placement - Barchart.com
Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill
RedHill Biopharma begins Korea enforcement of $10.9M judgment By Investing.com - Investing.com South Africa
RedHill Biopharma begins Korea enforcement of $10.9M judgment - Investing.com
RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo - Barchart.com
RDHL News | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - ChartMill
RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms - Sahm
RDHLRedhill Biopharma Ltd ADR Stock Price and Quote - Finviz
Redhill Biopharma stock soars on GLP-1 side effect treatment progress - Investing.com Nigeria
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104Important Step in RHB-204 Development for MAP-related Crohn's Disease - ChartMill
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights - Sahm
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical StudiesNew Data Presented at AACR 2026 - ChartMill
RDHL Stock Price, Quote & Chart | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - ChartMill
RedHill Biopharma receives Nasdaq notice on minimum bid price requirement By Investing.com - Investing.com South Africa
RedHill Biopharma receives Nasdaq notice on minimum bid price requirement - Investing.com India
Adi Frish details equity holdings in RedHill Biopharma (RDHL) Form 3 - Stock Titan
RDHL Earnings History & Surprises | EPS & Revenue Results | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - ChartMill
Joint U.S. Commercialization of RedHill's Talicia® Commences - ChartMill
Joint U.S. Commercialization of RedHill's Talicia Commences - Finviz
RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase - The Globe and Mail
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Benzinga
Redhill Biopharma stock soars on GLP-1 side effect treatment progress By Investing.com - Investing.com South Africa
RedHill advances once-daily ondansetron tablet for GLP-1 side effects By Investing.com - Investing.com India
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects - Chartmill
RedHill Biopharma regains compliance with Nasdaq listing requirements - Investing.com
RedHill Biopharma increases maximum amount for at-the-market ADS offering - Investing.com
Redhill Biopharma stock jumps after court win against Kukbo By Investing.com - Investing.com Canada
RedHill Biopharma to appeal Nasdaq compliance notice - Investing.com
Cumberland invests $4 million for 30% stake in RedHill’s Talicia business By Investing.com - Investing.com
Redhill Biopharma Ltd. (RDHL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
RedHill Biopharma stock surges after court upholds $10M judgment By Investing.com - Investing.com UK
RedHill Biopharma receives Nasdaq extension to regain compliance by October - Investing.com
Get insights into the top gainers and losers of Monday's after-hours session. - ChartMill
RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win - Finviz
RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - PR Newswire
Redhill Biopharma stock hits 52-week low at $2.47 amid steep annual decline - Investing.com
Redhill Biopharma stock hits 52-week low at $3 amid steep annual decline - Investing.com UK
Redhill Biopharma Ltd Share Price ADR Each Representing 1000 Ord Shares SPON - Hargreaves Lansdown
7 Undervalued Pharmaceuticals Stocks for Wednesday, August 07 - AAII
Trading Volume Is Your Friend - StocksToTrade
Curious about the stocks that are showing activity after the closing bell on Tuesday? - ChartMill
Opaganib eyed for Sulfur Mustard countermeasure By Investing.com - Investing.com South Africa
Wednesday's session: gap up and gap down stocks - ChartMill
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps. - ChartMill
大文字化:
|
ボリューム (24 時間):